Evidence map›Paper›PMID 27558110›Full record

ArticleEuropean journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology2016

Rapid detection of AAC(6')-Ib-cr production using a MALDI-TOF MS strategy.

C-A Pardo, R N Tan, C Hennequin, R Beyrouthy, R Bonnet, F Robin

Abstract read
PubMed Publisher
In one paragraph

Article in European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.7field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

C-A PardoLaboratoire de Bactériologie Clinique, CHU Clermont-Ferrand, 58, rue Montalembert, 63003, Clermont-Ferrand, France.
R N TanLaboratoire de Bactériologie Clinique, CHU Clermont-Ferrand, 58, rue Montalembert, 63003, Clermont-Ferrand, France.
C HennequinLaboratoire de Bactériologie Clinique, CHU Clermont-Ferrand, 58, rue Montalembert, 63003, Clermont-Ferrand, France. claire.hennequin@udamail.fr.
R BeyrouthyLaboratoire de Bactériologie Clinique, CHU Clermont-Ferrand, 58, rue Montalembert, 63003, Clermont-Ferrand, France.
R BonnetLaboratoire de Bactériologie Clinique, CHU Clermont-Ferrand, 58, rue Montalembert, 63003, Clermont-Ferrand, France.
F RobinLaboratoire de Bactériologie Clinique, CHU Clermont-Ferrand, 58, rue Montalembert, 63003, Clermont-Ferrand, France.
Centre Hospitalier Universitaire de Clermont-Ferrand · FRCNR de la Résistance aux Antibiotiques · FRUniversité Clermont Auvergne · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Plasmid-mediated quinolone resistance mechanisms have become increasingly prevalent among Enterobacteriaceae strains since the 1990s. Among these mechanisms, AAC(6')-Ib-cr is the most difficult to detect. Different detection methods have been developed, but they require expensive procedures such as Sanger sequencing, pyrosequencing, polymerase chain reaction (PCR) restriction, or the time-consuming phenotypic method of Wachino. In this study, we describe a simple matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) method which can be easily implemented in clinical laboratories that use the MALDI-TOF technique for bacterial identification. We tested 113 strains of Enterobacteriaceae, of which 64 harbored the aac(6')-Ib-cr gene. We compared two MALDI-TOF strategies, which differed by their norfloxacin concentration (0.03 vs. 0.5 g/L), and the method of Wachino with the PCR and sequencing strategy used as the reference. The MALDI-TOF strategy, performed with 0.03 g/L norfloxacin, and the method of Wachino yielded the same high performances (Se = 98 %, Sp = 100 %), but the turnaround time of the MALDI-TOF strategy was faster (<5 h), simpler, and inexpensive (<1 Euro). Our study shows that the MALDI-TOF strategy has the potential to become a major method for the detection of many different enzymatic resistance mechanisms.

Indexed as

BiotransformationDrug Resistance, BacterialAnti-Bacterial AgentsBacteriological TechniquesEnterobacteriaceaeNorfloxacinSensitivity and SpecificitySpectrometry, Mass, Matrix-Assisted Laser Desorption-IonizationTime FactorsAnti-Bacterial AgentsNorfloxacin

Identifiers

PMID27558110
OpenAlexW2510066124

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.